WhatsApp, WeChat & Telegram : +8801886229488, Email : aiopharma@outlook.com

Crizocent 250mg Crizotinib

Generic Name: Crizotinib

Manufacturer: Incepta Pharma

Capsule: 28’s Strip / 60’s Pot

Originator: Xalkori/ Crizalk by Pfizer

Contact For Order:

WhatsApp & WeChat: +8801886229488

Email: aiopharma@outlook.com

WeChat QR CodeAio Pharma QR code

Categories: ,

Crizocent 250mg Crizotinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer. it’s worked by blocking cancer cells.


FAQ about Crizocent 250mg Crizotinib


Q: How does Crizocent 250mg of Crizotinib work for lung cancer?

Crizotinib is a type of cancer growth blocker called a tyrosine kinase inhibitor. It works by blocking certain chemical messengers that tell cells to grow. This stops or slows down cancer.


Q: What is crizotinib used for?

Crizotinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer (NSCLC) that is caused by a defect in either a gene called anaplastic lymphoma kinase (ALK) or a gene called ROS1.


Q: How quickly does crizotinib work?

Official answer. We can estimate that Xalkori starts to work within approximately 2 months from graphs plotting progression-free survival, but most trials report on how long Xalkori keeps a person’s cancer from getting worse, not how quickly it works. This is called progression-free survival.


Q: Is crizotinib a chemotherapy?

Crizotinib is generic for the trade chemotherapy drug Xalkori. In some cases, healthcare professionals may use the trade name Xalkori when referring to the generic drug name crizotinib. Drug type: Crizotinib is a targeted therapy.


Product Description: Crizotinib is a kinase inhibitor indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive. Crizotinib is the first FDA-approved biomarker-driven therapy for both ALK-positive and ROS1-positive metastatic NSCLC. FDA has approved this drug as the only one for ROS 1-positive NSCLC.

Indication: CRIZONIX i is indicated for the first-line treatment of adults with ALK-positive advanced NSCLC and for the treatment of adults with previously treated ALK-positive advanced NSCLC  & ROS1 (+) NSCLC. Crizotinib is an ALK and ROS1 (c-ros oncogene 1, receptor tyrosine kinase) inhibitor.

Product Name : Crizocent
Generic Name : Crizotinib
Formulation : Capsule
Available size : 28’s
Strengths : 250mg


There are no reviews yet.

Be the first to review “Crizocent 250mg Crizotinib”

Your email address will not be published. Required fields are marked *